OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under solicitation SPE2DP26F2020, with an award date of July 23, 2026, for the provision of OMEPRAZOLE EXTENDED, identified by NSN 6505013142716. This award is issued as a delivery order under the existing contract SPE2DX25D9900, and the total contract price is detailed in the official award documentation. The procurement is classified as a federal acquisition, with no specific set-aside designation indicated, and the place of performance and organizational address details are unspecified. The contract is managed by the Department of Defense through the DLA, and all relevant information can be accessed via the provided DIBBS link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
